American Association for Cancer Research

SHERPA: Unknown

People

  1. Younes
    Younes
  2. Zelenetz
    Zelenetz
  3. Moskowitz
    Moskowitz
  4. Noy
    Noy
  5. Gerecitano
    Gerecitano
  6. Hamlin
    Hamlin
  7. Horwitz
    Horwitz
  8. Matasar
    Matasar
  9. Moskowitz
    Moskowitz
  10. Palomba
    Palomba

Groups

  1. Center for Hematologic Malignancies (40)
  2. Department of Medicine (40)
  3. Hematologic Malignancies, Division of (40)
  4. Lymphoma (40)
  5. Executive Committee, Center for Hematologic Malignancies (17)
  6. GSK Faculty (11)
  7. Adult Leukemia (8)
  8. Biostatistics Service (8)
  9. Epidemiology and Biostatistics (8)
  10. Sloan Kettering Institute Postdocs (8)
Search Within
  1. "Lymphoma"
Formats
  1. Meeting Abstract (20)
  2. Journal Article (18)
  3. Conference Paper (1)
  4. Editorial (1)
Groups
  1. Center for Hematologic Malignancies (40)
  2. Department of Medicine (40)
  3. Hematologic Malignancies, Division of (40)
  4. Lymphoma (40)
  5. Executive Committee, Center for Hematologic Malignancies (17)
  6. GSK Faculty (11)

More Groups

People
  1. Anas Younes (15)
  2. Andrew Zelenetz (14)
  3. David Straus (7)
  4. Ariela Noy (5)
  5. Craig Moskowitz (5)
  6. Alison Moskowitz (4)

More People

Years
  1. 2024 (1)
  2. 2022 (5)
  3. 2021 (1)
  4. 2020 (5)
  5. 2019 (4)
  6. 2018 (3)

More Years

Publications
  1. Cancer Research (22)
  2. Clinical Cancer Research (18)

Results (40)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Metabolic tumor volume response after bridging therapy determines chimeric antigen receptor T-cell outcomes in large B-cell lymphoma
    Journal Article

    Hubbeling, H.; Leithner, D.; Silverman, E. A.; Flynn, J.; Devlin, S.; Shah, G.; Fregonese, B.; Wills, B.; Bedmutha, A.; Alarcon Tomas, A.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Biomarker assessment of PTEN protein expression and gene expression profiling (GEP) in a phase III study of copanlisib in combination with rituximab in patients with indolent non-Hodgkin lymphoma (iNHL)
    Meeting Abstract

    Chaturvedi, S.; Schulz, A.; Soler, L. M.; Childs, B. H.; Matasar, M.; Zinzani, P. L.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • MSK-ACCESS Heme: A cell-free DNA next-generation sequencing assay to identify somatic alterations in patients with lymphoma
    Meeting Abstract

    DiNapoli, S. E.; Spence, C.; Gedvilaite, E.; Bowman, A.; Diosdado, M.; Razumova, A.; Tsui, D.; Salles, G. A.; Batlevi, C.; von Keudell, G.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Pharmacologically induced polyploidy triggers BCL2 dependence in lymphomas
    Meeting Abstract

    Portelinha, A.; da Silva Ferreira, M.; Erazo, T.; Asgari, Z.; de Stanchina, E.; Younes, A.; Wendel, H. G.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Adding umbralisib and ublituximab (U2) to ibrutinib in patients with CLL: A phase II study of an MRD-driven approach
    Journal Article

    Roeker, L. E.; Feldman, T. A.; Soumerai, J. D.; Falco, V.; Panton, G.; Dorsey, C.; Zelenetz, A. D.; Falchi, L.; Park, J. H.; Straus, D. J.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Phase I/Ib study of the efficacy and safety of buparlisib and ibrutinib therapy in MCL, FL, and DLBCL with serial cell-free DNA monitoring
    Journal Article

    Stewart, C. M.; Michaud, L.; Whiting, K.; Nakajima, R.; Nichols, C.; De Frank, S.; Hamlin, P. A. Jr; Matasar, M. J.; Gerecitano, J. F.; Drullinsky, P.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • CHRONOS-3: Randomized Phase III study of copanlisib plus rituximab vs rituximab/placebo in relapsed indolent non-Hodgkin lymphoma (iNHL)
    Meeting Abstract

    Matasar, M. J.; Capra, M.; Özcan, M.; Lv, F.; Li, W.; Yañez, E.; Sapunarova, K.; Lin, T.; Jin, J.; Jurczak, W.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Inhibition of PIM kinases targets synthetic vulnerabilities and enhances antigen presentation in B cell lymphoma
    Meeting Abstract

    Mondello, P.; Tarantelli, C.; Cascione, L.; Arribas, A. J.; Rinaldi, A.; Younes, A.; Bertoni, F.
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Multispectral immunofluorescence identifies pS6 as a biomarker of intrinsic resistance to ruxolitinib in patients with relapsed/refractory T-cell lymphomas
    Meeting Abstract

    Ghione, P.; Moskowitz, A.; Kumar, P.; Knezevic, A.; Seshan, V.; Jacobsen, E.; Ruan, J.; Schatz, J.; Noor, S.; Myskowski, P.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Nitrogen trapping as a therapeutic strategy in tumors with mitochondrial dysfunction
    Journal Article

    Madala, H. R.; Helenius, I. T.; Zhou, W.; Mills, E.; Zhang, Y.; Liu, Y.; Metelo, A. M.; Kelley, M. L.; Punganuru, S.; Kim, K. B.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save

    • American Association for Cancer Research – authorized name for: